Do you want to play a key role in improving the treatment options for patients with endometriosis and other inflammatory/ pain conditions?
We are looking for a VP Clinical Development with extensive experience in clinical development from R&D in the pharmaceutical or biotech industry. This position involves high-level strategic planning as well as hands-on responsibility for overseeing the planning, execution, and management of clinical development programs for new drug candidates. You will report to the CEO and be a member of the executive and R&D management teams.
Please contact our recruitment partner, Haeger & Carlsson, for any questions:
Gesynta Pharma bases its R&D on groundbreaking research from the Karolinska Institutet.
Our executive team and board of directors hold vast experience in drug development, commercialization and company scale-up.
Endometriosis is a chronic, inflammatory, estrogen-dependent disease affecting millions of women worldwide.
Our lead drug candidate vipoglanstat is in clinical phase II, while GS-073 is ready to enter clinical phase I.